梅里埃诊断

bioMérieux, established in 1963, relies on its own technological innovation and industrial production resources to focus on in-vitro diagnostic products for medical and industrial uses. The company's diagnostic systems consist of reagents, instruments, and software, primarily designed around four strategic areas: infectious diseases, industrial microbiology, cardiovascular diseases, and oncology.

As the core business of the Mérieut Institute, bioMérieux aims to contribute to global public health through in-vitro diagnostics. The two main business areas of bioMérieux are:
- Clinical Diagnostics: Focused on infectious diseases, also covering oncology and cardiovascular emergencies.
- Industrial Microbiology: Food, pharmaceuticals, animal health, and cosmetics.

Clinical diagnostics play a crucial role in the healthcare process. Through diagnostic tests, pathogens (such as bacteria, viruses, fungi) and body fluids can be detected and identified, providing accurate results that inform medical decisions, significantly improving treatment effectiveness and safety, reducing hospital infections and overall medical costs, addressing new pathogen diagnoses, antibiotic resistance, and other public health issues. This makes it an essential tool for personalized and precision medicine.

Headquartered in Lyon, France, bioMérieux currently offers over 2,000 products. It operates 19 industrial production facilities, 20 research and development bases, and has a presence in six continents across 150 countries, with offices in 42 regions and approximately 10,000 employees worldwide.

With over 50 years of experience, bioMérieux now plays a significant role in the global in-vitro diagnostics industry, ranking among the top ten diagnostic companies worldwide and being a leader in clinical and industrial microbiology.

For over 55 years, bioMérieux has been a world leader in in-vitro diagnostics, designing, developing, producing, and marketing diagnostic solutions (systems, reagents, software, and services) for clinical and industrial applications, determining the source of a disease or contamination to improve patient health and ensure consumer safety.

bioMérieux is present in 43 countries and serves more than 160 countries through a vast network of distributors. Its corporate headquarters are located in Marcy l’Etoile, near Lyon, France.

Joining bioMérieux means becoming part of an innovative company with a long-term vision, committed to public health service and guided by a humanistic corporate culture. Our group offers numerous opportunities—join the 11,200 bioMérieux employees who already embody these values!